BIOMEDICAL REPORTS, 2024 · DOI: 10.3892/br.2024.1823 · Published: June 28, 2024
This study aimed to understand how different doses of oxybutynin affect bladder pressure in people with neurogenic bladder caused by spinal cord injury. The researchers reviewed hospital records of patients with these conditions, looking at bladder pressure before and after oxybutynin treatment. The study found that a higher dose of oxybutynin was linked to a lower bladder pressure, suggesting the drug is effective for managing this condition.
The study provides guidance for setting the starting dose of oxybutynin in patients with NGB and SCI.
Physicians can adjust the optimal dosage of oxybutynin based on individual detrusor pressure and bladder management methods.
Oxybutynin is clinically effective for managing NGB in patients with SCI.